EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 47 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,097 | -51.0% | 9,441 | -33.7% | 0.00% | – |
Q2 2023 | $110,306 | +17.4% | 14,233 | +1.0% | 0.00% | – |
Q1 2023 | $93,994 | -30.5% | 14,092 | -6.9% | 0.00% | – |
Q4 2022 | $135,280 | +17.6% | 15,132 | +29.0% | 0.00% | – |
Q3 2022 | $115,000 | +13.9% | 11,733 | -7.7% | 0.00% | – |
Q2 2022 | $101,000 | -37.3% | 12,712 | -23.5% | 0.00% | – |
Q1 2022 | $161,000 | -50.0% | 16,617 | -21.3% | 0.00% | – |
Q4 2021 | $322,000 | +192.7% | 21,104 | +218.6% | 0.00% | – |
Q3 2021 | $110,000 | -69.7% | 6,624 | -61.1% | 0.00% | – |
Q2 2021 | $363,000 | – | 17,031 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $12,367,000 | 8.01% |
Cormorant Asset Management, LP | 3,850,000 | $30,646,000 | 2.32% |
Novo Holdings A/S | 5,587,207 | $44,474,000 | 2.19% |
Orbimed Advisors | 14,082,680 | $112,098,000 | 2.03% |
Opaleye Management Inc. | 451,400 | $3,593,000 | 1.62% |
DAFNA Capital Management LLC | 695,959 | $5,540,000 | 1.51% |
EcoR1 Capital, LLC | 2,359,808 | $18,784,000 | 0.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $31,308,000 | 0.65% |
Resolute Capital Asset Partners LLC | 89,190 | $710,000 | 0.51% |
HighVista Strategies LLC | 103,462 | $824,000 | 0.50% |